RT Journal Article
SR Electronic
T1 Comparative evaluation of the transmissibility of SARS-CoV-2 variants of concern
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.25.21259565
DO 10.1101/2021.06.25.21259565
A1 Liang Wang
A1 Xavier Didelot
A1 Yuhai Bi
A1 George F Gao
YR 2021
UL http://medrxiv.org/content/early/2021/06/30/2021.06.25.21259565.abstract
AB Since the start of the SARS-CoV-2 pandemic in late 2019, several variants of concern (VOC) have been reported, such as B.1.1.7, B.1.351, P.1, and B.1.617.2. The exact reproduction number Rt for these VOCs is important to determine appropriate control measures. Here, we estimated the transmissibility for VOCs and lineages of SAR-CoV-2 based on genomic data and Bayesian inference under an epidemiological model to infer the reproduction number (Rt). We analyzed data for multiple VOCs from the same time period and countries, in order to compare their transmissibility while controlling for geographical and temporal factors. The lineage B had a significantly higher transmissibility than lineage A, and contributed to the global pandemic to a large extent. In addition, all VOCs had increased transmissibility when compared with other lineages in each country, indicating they are harder to control and present a high risk to public health. All countries should formulate specific prevention and control policies for these VOCs when they are detected to curve their potential for large-scale spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge the Authors from the Originating laboratories and the Submitting laboratories where genetic sequence data were generated and shared via GISAID, enabling this research. This work was supported by the intramural special grant for SARS-CoV-2 research from the Chinese Academy of Sciences, the Strategic Priority Research Programme of the Chinese Academy of Sciences (Grant numbers XDB29010102), National Natural Science Foundation of China (NSFC) (Grant numbers 32041010 and 31900155). Y.B. is supported by the NSFC Outstanding Young Scholars (Grant number 31822055) and Youth Innovation Promotion Association of CAS (Grant number 2017122).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no experiment in this manuscript need to be approved by IRB and/or ethics committeeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this manuscript is available in GISAID